IR contact detailsRoman Akbar-HaaseDirector Investor Relations and Business Developmente: ir@moonlaketx.com Upcoming events Sep 14 - Sep 16 2026 Morgan Stanley 24th Annual Global Healthcare Conference Sep 23 - Sep 24 2026 Stifel 2026 Virtual Immunology and Inflammation Forum Sep 30 - Oct 3 2026 EADV Congress 2026 View All Events View All Events + Corporate presentations MoonLake Investor Day (Jun 2026) MoonLake Investor Day (Feb 2026) Clinical Data Update (Nov 2025) View All Presentations View All Presentations + Latest press releases Aug 10 2026 MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results Jun 23 2026 MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering Jun 22 2026 MoonLake Immunotherapeutics Announces Proposed Public Offering View All News View All Press Releases +
Aug 10 2026 MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results